We demonstrated that the drug transport activity of ABCB1 and ABCG2 could extensively lower the intracellular accumulation of HS-173 and consequently reduce its ability to induce G2/M phase cell cycle arrest and apoptosis in human cancer cells. The gene discussed is ABCG2; the disease is cancer.